↓ Skip to main content

Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study

Overview of attention for article published in Clinical Lymphoma, Myeloma & Leukemia, January 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study
Published in
Clinical Lymphoma, Myeloma & Leukemia, January 2019
DOI 10.1016/j.clml.2019.01.003
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 9 15%
Student > Doctoral Student 6 10%
Other 5 8%
Student > Master 5 8%
Researcher 5 8%
Other 6 10%
Unknown 24 40%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 19 32%
Biochemistry, Genetics and Molecular Biology 8 13%
Business, Management and Accounting 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Immunology and Microbiology 2 3%
Other 3 5%
Unknown 23 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2019.
All research outputs
#30,849,761
of 34,043,423 outputs
Outputs from Clinical Lymphoma, Myeloma & Leukemia
#2,372
of 2,648 outputs
Outputs of similar age
#434,306
of 488,434 outputs
Outputs of similar age from Clinical Lymphoma, Myeloma & Leukemia
#22
of 32 outputs
Altmetric has tracked 34,043,423 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,648 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 488,434 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.